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Abstract
Regulation of blood flow through the testicular microvasculature by vasomotion is thought to be important for normal
testis function as it regulates interstitial fluid (IF) dynamics which is an important intra-testicular transport medium.
Androgens control vasomotion, but how they exert these effects remains unclear. One possibility is by signalling via
androgen receptors (AR) expressed in testicular arteriole smooth muscle cells. To investigate this and determine the overall
importance of this mechanism in testis function, we generated a blood vessel smooth muscle cell-specific AR knockout
mouse (SMARKO). Gross reproductive development was normal in SMARKO mice but testis weight was reduced in
adulthood compared to control littermates; this reduction was not due to any changes in germ cell volume or to deficits in
testosterone, LH or FSH concentrations and did not cause infertility. However, seminiferous tubule lumen volume was
reduced in adult SMARKO males while interstitial volume was increased, perhaps indicating altered fluid dynamics; this was
associated with compensated Leydig cell failure. Vasomotion was impaired in adult SMARKO males, though overall testis
blood flow was normal and there was an increase in the overall blood vessel volume per testis in adult SMARKOs. In
conclusion, these results indicate that ablating arteriole smooth muscle AR does not grossly alter spermatogenesis or affect
male fertility but does subtly impair Leydig cell function and testicular fluid exchange, possibly by locally regulating
microvascular blood flow within the testis.
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Introduction
Testosterone is essential for normal male fertility, controlling
development of the male reproductive system [1] and the later
initiation and maintenance of spermatogenesis [2,3]. Testosterone
is produced by the testicular Leydig cells (LC) and binds to the
androgen receptor (AR) to modulate gene transcription in target
cells [4]. ARs are expressed in several testicular cell types [5,6] and
recent investigations showed that ablating AR specifically from
Sertoli cells (SC) or peritubular myoid cells (PTM) results in male
infertility [7,8,9]. Conversely, germ cells (GC) lacking AR develop
normally [10,11]. AR is also expressed in other testicular cell types
including the arteriole smooth muscle cells [6,12], and it has been
suggested that androgen signalling via the arterioles may play a
role in regulating testicular function and male fertility [12];
however, how androgens mediate these effects remains unknown.
The vascular system forms early in testis development [13,14]
and normal testis function depends on the vascular system
delivering oxygen, nutrients and hormones into testicular
interstitial fluid (IF) and removing waste and secretory products;
for example testicular blood flow positively correlates with serum
testosterone concentrations [15]. There are several aspects of
blood flow in the testis that are unique, including low blood
oxygen tension and non-pulsatile blood flow [16,17]. Furthermore,
the bulk of the testis (i.e. the highly proliferative seminiferous
tubules) is avascular therefore it relies on IF for transport of
nutrients and hormones; this fluid transport itself is influenced by
hormones, for example luteinising hormone (LH) increases
testicular vascular permeability [17] by increasing vascular
endothelial growth factor (VEGF) production [12,18,19]. Main-
taining normal blood flow through the testicular microvasculature
relies on a balance of events at the pre- and post-capillary beds and
it has been suggested that steroid hormones may play a role in
regulating this [12], but the exact mechanisms remain under
explored.
Testicular microvasculature blood flow is thought to be
regulated locally and shows regular rhythmical variations, known
as vasomotion [20,21,22]. Vasomotion is present in most vascular
beds [17], is independent of heart beat, can be influenced by
hypoxia and hormones [20,21,22,23,24], and is thought to be
mediated by the vascular smooth muscle cells [17]. Vasomotion
mediates the transfer of fluids between blood plasma and IF,
therefore fluid transfer, and hence IF volume and content, is easily
influenced by changes in testicular blood flow [25] and vasomotion
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[20,21,22]. When the testicular microvasculature dilates, blood
flows through quickly and plasma filters from the blood into the
interstitium, whilst slow or stops in flow due to microvasculature
constriction allows fluids to filter from the interstitium back into
the blood [22]. Several lines of evidence point to testosterone as
one of the key factors controlling vasomotion and testicular blood
flow, which in turn affects fluid dynamics and testis function
[17,26].
In the testis, ARs are expressed in arteriole smooth muscle cells,
but not in arteriole endothelial cells or in venules or capillaries [6].
Interestingly, ARs are not expressed in the arteriole smooth muscle
cells in all organs (e.g. the kidney [6]), therefore suggesting a
specific local role for AR in the testicular vasculature. AR
expression in testicular arterioles depends on sufficient intra-
testicular testosterone concentrations and signalling via these ARs
may mediate some of the effects of androgens on testicular
microcirculation [6]. Alternatively, testosterone could affect blood
flow by signalling via the LCs or other AR positive testicular
somatic cells, such as the SC or PTM cells, which in turn signal to
the blood vessels. The aim of our studies was to directly investigate
the role for testicular vascular smooth muscle AR in testis function
and male fertility.
Materials and Methods
Breeding of transgenic mice
We generated mice in which the AR has been selectively
ablated from the arteriole smooth muscle cells using Cre/loxP
technology; some of the mice used in this study were generated
previously in a comparative study of the specificity of the sm22-
Cre line and the MHC-cre line [8]. Male mice heterozygous for
Cre Recombinase under the control of a smooth muscle 22 a [27]
promoter were mated to female mice homozygous for a floxed AR
[7]; all mice are maintained on a C57BL6 background. As
previously reported [8], Cre positive (ARflox positive) male offspring
from these matings are termed SMARKO, while the Cre negative
ARflox positive littermates were used as controls (termed control or
C). Cre positive, ARflox negative mice were also generated to
confirm that expression of Cre alone did not induce a phenotype
[8]. All mice were bred under standard conditions of care and use
under licensed approval from the UK Home Office (Project
licence 60/3544). Mice were genotyped from ear or tail DNA for
the presence of Cre and/or ARflox using standard PCR ([8] and
http://jaxmice.jax.org/protocolsdb/f?p=116:2:3392087113007235::
NO:2:P2 _MASTER_PROTOCOL_ID,P2_JRS_CODE:288,004746);
the internal positive control used in the Cre genotyping assay is
Interleukin-2, as recommended by the Jackson Laboratory.
Evaluation of fertility
To investigate fertility, d100 SMARKO and control males were
each housed with an adult C57BL/6J female for 4 days. This was
repeated with 3 subsequent C57BL/6J females per male. Female
mice were monitored for 25 days for litters to be born.
Recovery of reproductive tissues
Male mice were culled at various postnatal ages (d12–d300) and
reproductive tissues were collected, weighed and snap-frozen or
fixed in Bouins as previously described [8]. Bouins fixed tissues
were processed and embedded in paraffin wax and 5 mm sections
were cut for histological analysis as previously described [28].
Sections of testis and epididymis were stained with hematoxylin
and eosin using standard protocols and examined for histological
abnormalities.
Hormone analysis
Immediately after culling, blood was collected from d50 and
d100 KO and control mice by cardiac puncture and sera were
assayed for FSH, LH and testosterone as previously published
[29,30]. Intra-testicular testosterone concentrations were mea-
sured as previously published [31]. All samples were run in a single
assay for each hormone, and the within-assay coefficients of
variation were all ,10%.
Treatment with hCG
SMARKO (n= 6) and control (n = 15) adult male mice were
injected subcutaneously with 20IU hCG in 0.2 ml saline (Organon
Laboratories, Cambridge, UK) 16 h prior to culling. Mice were
culled and blood was collected by cardiac puncture to measure
serum testosterone and testes were recovered and weighed, as
detailed above. IF was collected from testes as previously published
[32,33] and assayed for testosterone.
Vasomotion measurements
Vasomotion was measured in SMARKO (n= 7) and control
(n = 13) d100 male mice using previously published Doppler
flowmeter methodology [21,22]. Mice were anaesthetised by
subcutaneous injection of 10 ml/kg ketaminol (10 mg/ml) and
narcoxyl (1 mg/ml) in sterile water. The probes, which measure
flow in a tissue volume of approximately 2 mm3, were held with a
micromanipulator approximately 1 mm above an area of the
testicular surface devoid of large vessels. The laser Doppler flow
signals were recorded for at least 5 min on the surface of both
testes and average blood flow and vasomotion frequency were later
analysed using the software Perisoft for Windows 1.01 (Perimed
AB). As focal areas of seminiferous tubule abnormalities could be
identified in SMARKO testes, flow was examined at multiple spots
over each testis surface in both control and KO mice to ensure
that data represented vasomotion throughout the testis and not
just in ‘normal’ or ‘abnormal’ areas; no obvious differences were
seen in recordings at different locations within each tests.
Determination of testicular cell composition
Standard stereological techniques involving point counting of cell
nuclei were used as previously described [7,34], to determine the
nuclear volume per testis of SC, GCs, LCs, blood vessels and the
relative volumes of interstitium, and seminiferous tubule lumen in
SMARKO and control mice at d100 (n=4–6). In brief, testicular
cross sections were examined using a Leitz 363 plan apo objective
lens (x63) fitted to a Leitz Laborlux microscope and a 121-point
eyepiece graticule (Leica Microsystems, Wetzlar, Germany). For
each animal, 32–64 microscopic fields were counted, and values for
percent nuclear volume were converted to absolute nuclear volumes
per testis by reference to testis volume ( = weight). SC and LC
nuclear size, blood vessel number and size, proportion interstitium
and lumen, and seminiferous tubule diameter were determined
using an Olympus Optical BH-2 microscope (Olympus Optical Co.,
Tokyo, Japan) fitted with a Prior automatic stage (Prior Scientific
Instruments, Cambridge, UK) and Image-Pro Plus (version 4.5.1)
with Stereologer-Pro 5 plug-in software (Media Cybernetics,
Bethesda, MD, USA). The ‘abnormal’ seminiferous tubules were
not excluded from these analyses. Data were used to determine: (i)
the relative contribution of seminiferous tubule lumen and
interstitium to the testis volume (expressed as a % and as actual
volume per testis); (ii) average seminiferous tubule diameter; (iii) the
nuclear volumes of and number of SCs and LCs per testis; (iv) the
nuclear volume per testis of each type of GC; and (v) the average
number and size of blood vessels per testis.
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Immunohistochemical analysis
As well as PCR genotyping, d100 mice were examined by
immunohistochemistry for the presence of Cre using a previously
published method [8]. Single colorimetric immunohistochemis-
try was also performed on d100 testes for WT-1 to demonstrate
the location of SC nuclei and for 3b-HSD to highlight LCs [8].
Briefly, sections were deparaffinized, rehydrated, and antigen
retrieved before blocking of nonspecific binding sites, as detailed
previously [28]. Sections were incubated overnight at 4uC with
the primary antibody diluted accordingly as detailed in Table 1.
Immunostaining was detected using the secondary antibody and
detection system specified in Table 1. Diaminobenzidine (DAB)
immunostained slides were counterstained with hematoxylin,
dehydrated, and mounted with Pertex (Histolab, Gothenburg,
Sweden), and images were captured using a Provis microscope
(Olympus) equipped with a Kodak DCS330 camera (Eastman
Kodak, Rochester, NY, USA). Fluorescent immunostained
sections were mounted in Mowiol mounting medium (Calbio-
chem, San Diego, CA, USA), and fluorescent images were
captured using a Zeiss LSM 510 Meta Axiovert 100 M confocal
microscope (Carl Zeiss Ltd., Welwyn, UK). To ensure
reproducibility of results representative testes from at least 3
animals at each age were used, and sections from SMARKO
and control littermates were processed in parallel on the same
slide on at least 2 occasions. Slides were incubated with normal
serum alone as a negative control to ensure that any staining
observed was specific.
RNA extraction and reverse transcription
RNA was isolated from d100 frozen testes from SMARKO or
control mice, using RNeasy Mini extraction kit with RNase-free
DNase on the column digestion kit (Qiagen, Crawley, UK)
according to the manufacturer’s instructions, and quantified using
previously published methods [8]. Random hexamer primed
cDNA was prepared using the Applied Biosystems TaqManH
reverse transcription kit (Applied Biosystems, Foster City, USA)
according to manufacturers’ instructions.
Determination of deletion of AR exon 2
RT-PCR was performed on cDNA synthesised from testes from
d100 SMARKO mice and control littermates using primers for AR
exon 1 and 3, as previously described [8].
Quantitative analysis of gene expression
Quantitative PCR was performed on d21 or 100 SMARKO
and control testes for steroidogenesis enzymes and the LC
differentiation marker Insulin-like factor 3 (Insl3). Primers are
detailed in Table 2, using an ABI Prism 7500 Sequence Detection
System (Applied Biosystems) and the Roche Universal Probe
library (Roche, Welwyn, UK), as previously described [8]. The
expression of each gene was related to luciferase, an external
positive control, and all genes were expressed per testis.
Statistical Analysis
Data were analyzed using GraphPad Prism version 5 (Graph
Pad Software Inc., San Diego, USA) using a 2-tailed unpaired t
test or a 1-way ANOVA followed by Bonferroni post-hoc tests.
Values are expressed as mean 6 SEM. Normality was confirmed
using D’Agostino & Pearson omnibus normality test.
Results
Generation and characterisation of mice with a selective
deletion of AR from blood vessel smooth muscle cells
As previously reported [8], no reproductive phenotype was
identified in adult SM Cre positive, ARflox negative male mice
demonstrating that expression of Cre alone had no effect (data not
shown). All SMARKO males were hemizygous for X-linked ARflox
while approximately 50% of these males also carried the Cre
transgene (representative example of genotyping results shown in
Figure 1A; knockout - KO); the ARflox positive Cre negative male
littermates were used as controls. To confirm that Cre Recombi-
nase was functioning in these mice we assayed for the deletion of
exon 2 of the AR in SMARKO testes by RT-PCR. As previously
reported [8], SMARKO control testes only expressed the full
length (WT) band whereas ARKO testes only expressed the
smaller KO band, confirming that exon 2 of the AR had been
deleted from all cells (Figure 1B); testes from SMARKO mice
expressed both the WT and the KO band, demonstrating that AR
had been deleted only from a proportion of testicular cells
(Figure 1B). Immunohistochemistry was therefore undertaken in
d100 testes to identify which cells in the testes expressed Cre
Recombinase. As previously published [8], testes from Cre
negative ARflox positive control mice showed no specific testicular
Cre Recombinase immunoexpression at d100, while every smooth
muscle cell around the blood vessels immunostained for Cre
Recombinase in SMARKO mice (Figure 1C). Cre Recombinase
was never expressed in any other testicular cell type in SMARKO
mice, including the smooth muscle peritubular myoid cells. The
sm22-Cre mice were also used in a previous study to reportedly
target AR in the peritubular myoid cells [35]; however, we [8] and
others [36] have unequivocally demonstrated that the sm22
promoter drives Cre expression in the testicular arteriole smooth
muscle cells but not in any other testicular cell type. Cre
recombinase is also expressed in the arteriole smooth muscle cells
outside the testis, such as the aorta [36]. We cannot completely
rule out any global effect on blood flow affecting the testis,
however, testicular blood flow is believed to be independent of
heartbeat and regulated locally [20,21,22] therefore any effect on
the aorta is unlikely to have any significant effect on the testis.
Table 1. Immunohistochemistry antibody details.
Antibody Antibody source Dilution Detection system
3bHSD Santa Cruz (Santa Cruz, USA) 1:4000 Tyramide 546
AR Santa Cruz 1:50 Goat anti-rabbit alexa 488
Cre/SMA Cre Abcam 1:5000 Tyramide 488
SMA Sigma 1:500 Goat anti-mouse alexa 633
WT-1 Dako 1:1000 Goat anti-mouse biotinylated + DAB
doi:10.1371/journal.pone.0013632.t001
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Characterisation of the reproductive system in SMARKO
mice
Bodyweight was not significantly different between
SMARKO and control males at any age (data not shown).
SMARKO males were normally fertile (data not shown) and, in
contrast to ARKO mice [7], the reproductive tract formed
normally in SMARKO males (Figure 2A). Testis descent and
external sexual development were normal in SMARKO males,
with no significant reduction in anogenital distance (AGD) or
penis length (data not shown). Seminal vesicle and ventral
prostate weights were also normal in SMARKO males at d100,
compared to control littermates (Figure 2B) and no obvious
abnormalities were observed in the epididymis in SMARKO
adult males (data not shown). Testis weight was normal at d12 -
35 (Figure 2C) but was significantly smaller in SMARKO mice
than in control littermates at d50 onwards (Figure 2C); note that
testis weight did not change significantly in the KO males
between d100 and d300. Expression of Cre alone, without ARflox
expression, had no effect on testis weight at d100 (data not
shown).
Table 2. Taqman primer details.
Gene Forward primer Reverse primer
Steroidogenic acute regulatory protein (StAR) ttgggcatactcaacaacca Acttcgtccccgttctcc
3b-hydroxysteroid dehydrogenase (3bHSD) tgtgaccatttcctacattctga ccagtgattgataaaccttatgtcc
17b-hydroxysteroid dehydrogenase (17b HSD) aatatgtcacgatcggagctg gaagggatccggttcagaat
Cytochrome p450 11a (cyp11a or p450scc) aagtatggccccatttacagg tggggtccacgatgtaaact
Cytochrome p450 17 (cyp17 or 17aOH) catcccacacaaggctaaca cagtgcccagagattgatga
Vascular endothelial growth factor A (VEGF-A) gtacctccaccatgccaagt tgggacttctgctctccttc
Insulin-like factor 3 (Insl3) aagaagccccatcatgacct tttatttagactttttgggacacagg
doi:10.1371/journal.pone.0013632.t002
Figure 1. Characterisation of Cre Recombinase expression in adult SMARKO testes. A. Approximately 50% of male SMAR were Cre positive
(KO), identified by the presence of a band at 100 bp. Control (C) littermates were negative for Cre. B. Deletion of androgen receptor (AR) in the testes
was determined using RT-PCR spanning exon 2. Only the larger 765 bp wild-type (WT) AR band was seen in control testes while the smaller 613 bp
KO band was seen in ARKO testes. Both bands were identified in SMARKO testes, showing deletion of AR in a proportion of cells.
C. Immunohistochemistry for Cre Recombinase (green) and smooth muscle actin (SMA, blue) showed that Cre Recombinase was expressed
selectively (arrow) in the smooth muscle cells surrounding the blood vessels in adult SMARKO testes but not in any other testicular cell types or in any
cells in control testes (arrowhead).
doi:10.1371/journal.pone.0013632.g001
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Postnatal testis morphology and cell numbers
Spermatogenesis and testicular histology appeared normal in
the majority of seminiferous tubules from SMARKO males at
d100 (Figure 3A); however, around 10% of seminiferous tubules
appeared abnormal in SMARKO testes, with vacuoles and
reduced depth of seminiferous epithelium and disrupted sper-
matogenesis (Figure 3A, right panel). This did not result in any
significant change in seminiferous tubule diameter but there was a
significant reduction in seminiferous tubule lumen volume per
testis in SMARKOs at d100 (Figure 3C–E). There was no
significant change in the total volume of GCs (Figure 3B) or in the
number of any type of GC (data not shown) in adult SMARKOs,
compared to control littermates.
Impact of SMARKO on Leydig cell function and hormone
profiles
A significant increase in interstitial volume (Figure 4A), and
percentage interstitium (data not shown) was observed in d100
SMARKOs, compared to control littermates. Testes were
immunostained for 3b-HSD and AR to highlight that AR is
expressed in LCs in both control and KO testes at d100 (arrow,
Figure 4B). Quantification revealed that there was no significant
increase in LC size and number in SMARKO mice at d100,
compared to controls (Figure 4C). There was a significant increase
in relative expression of cyp11a, 3bHSD, and Insl3 in SMARKO
d100 testes compared to controls, while expression of other genes
involved in steroidogenesis (namely StAR, Cyp17 and 17bHSD)
were not significantly changed (Figure 4D). Serum follicle
stimulating hormone (FSH) concentrations were not significantly
changed at d100 in SMARKO males, compared to controls
(Figure 5A). In contrast, serum Luteinizing hormone (LH) was
increased in SMARKO males at d100, but not at d50, compared
to controls (Figure 5B). Serum testosterone concentrations were
not significantly altered in SMARKO mice at d50 or d100
compared to controls (Figure 5C) and there was no significant
change in intra-testicular testosterone concentrations (expressed
per 100 mg testis) in SMARKO testes, compared to controls
(Figure 5D).
Impact of SMARKO on SC function
As expected, SC nuclei (identified by WT-1 expression) were
observed at the base of seminiferous tubules in SMARKO and
control mice at d100 and SC nuclear volume per testis (equates to
SC number) was not significantly altered in SMARKO testes at
d100, compared to controls (Figure 6). Furthermore, expression
of SC-specific genes previously shown to be androgen-indepen-
dent (androgen binding protein, ABP, [37]) or androgen-
dependent (Rhox5, Eppin and Tubb3 [38]) were not significantly
Figure 2. Gross morphology of the reproductive system from SMARKOmice. A. Urogenital tract from males at d100 in which the testes (T)
are slightly smaller in the SMARKO than in controls while the seminal vesicles (arrow) are not different in size. B. Quantification of seminal vesicle and
ventral prostate weight in SMARKO and control (C) mice at d100. C. Quantification of testis weight in SMARKO and control mice from d12-300. Values
are means 6 S.E.M. (n = 6–22 mice), * p,0.05 compared to controls.
doi:10.1371/journal.pone.0013632.g002
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changed in SMARKO testes at d100, compared to control
littermates (data not shown). Note that AR was expressed in SCs
in both control and SMARKO testes at d100 (arrowhead,
Figure 4B).
Vasomotion in SMARKO testes
A regular high amplitude (sinus curve-like) vasomotion pattern
was present in control testes (14 of 14 males), as expected
(Figure 7A, right panel). Conversely, vasomotion persisted in
71% (5 of 7 males) of SMARKO testes (Figure 7A, middle panel)
but was markedly disturbed while no vasomotion was detected in
2 SMARKO males (Figure 7A, right panel). Compared to
controls, vasomotion frequency and amplitude were both
significantly reduced in those SMARKO testes which retained
some degree of vasomotion (Figure 7B and C respectively).
There was no significant difference in average blood flow in
SMARKO testes compared to controls (Figure 7D). There was a
significant increase in the proportion of blood vessels in
SMARKO adult testes compared to controls (Figure 7E); this
appeared to be due to an increase in average blood vessel size
(data not shown, p = 0.09) rather than any changes in the
number of blood vessel cross sections per testis (data not shown,
p = 0.8). There was no significant effect on VEGF-A mRNA
expression in SMARKO testes at d21 or d100, compared to
controls (data not shown).
Response to hCG exposure
It is well documented that exposure to hCG increases blood
vessel permeability and inhibits vasomotion resulting in increased
IF volume in adult rats [20,39,40,41]. In this study, exposure to
hCG 16 h prior to cull resulted in a significant increase in testis
weight in adult control mice, reflecting increased IF volume, but
not in SMARKO adults (Figure 8A). hCG also significantly
increased serum testosterone concentrations in both SMARKO
and controls (Figure 8B), however, there was only a 3-fold increase
in SMARKO mice compared to a 7-fold increase in control mice.
IF testosterone concentrations were significantly increased in
control mice after hCG exposure, compared to SMARKOs
(Figure 8C). Exposure to hCG prevented vasomotion in 71% of
control adult mice (5 of 7 males) and prevented vasomotion in all
Figure 3. Histological comparison of adult SMARKO and control testes. A. Most seminiferous tubules in SMARKO testes looked comparable
to control testes at d100, however, a small proportion (10%) were abnormal with disturbed spermatogenesis (*). Lumens appeared smaller in many
seminiferous tubules in SMARKO testes at d100, compared to controls. B. There was no significant change in the total germ cell volume in SMARKO
testes at d100, compared to controls. C. There was no significant change in seminiferous tubule diameter in SMARKO testes at d100, compared to
controls. The percentage (D) and volume (E) of seminiferous tubule lumen was significantly reduced at d100 in SMARKO testes compared to
controls. Scale bars = 50 mm. Values are means 6 S.E.M. (n = 4–6 mice), * p,0.05, ** p,0.01 compared to controls littermates.
doi:10.1371/journal.pone.0013632.g003
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SMARKO adult mice (5 of 5 males). This lack of vasomotion in
hCG treated control or SMARKO mice resulted in a small but not
significant increase in testicular blood flow (Figure 8D). Vasomo-
tion frequency and amplitude were both significantly reduced in
the two hCG-treated control mice in which vasomotion persisted
(Figure 8E and F).
Discussion
The role for androgens in vascular function has been recognised
for several decades [42,43] yet the cellular mechanisms remain
rather elusive. For example, it is not clear how testosterone
regulates testicular blood flow or what role testicular arteriole
smooth muscle ARs play in testicular function. Mice completely
lacking a functional AR have been used to study the effects of
androgens on the cardiovascular system [44,45], however, the
effects on the testes cannot be studied in these mice as they have
reduced circulating testosterone concentrations and cryptorchi-
dism and AR is deleted from all cell types therefore potentially
masking the effects of AR in the blood vessels. We therefore
investigated the effects of androgens on the testicular vasculature
directly using an arteriole smooth muscle cell specific ARKO
mouse (termed SMARKO) [8]. We demonstrate that ablating
arteriole smooth muscle AR has no gross effect on spermatogenesis
or on male fertility. However, detailed analysis revealed that LC
function, vasomotion and fluid dynamics within the testis were
impaired in SMARKO mice, indicating a role for androgen
signalling via the blood vessels in locally regulating LC function
and microvascular blood flow.
Ablation of AR from the vascular smooth muscle cells had no
effect on reproductive tract formation, testes descent or adult
prostate or seminal vesicle size. Conversely, testis size was
significantly reduced in adulthood, but was not affected prior to
puberty (i.e. at d12, 21 or 35). Note though that testis size does not
significantly change between d100 and d300 and the degree of
histological abnormalities was not increased in d300 SMARKO
testes compared to d100 testes (data not shown), suggesting that
lack of AR in the smooth muscle cells of the blood vessels causes an
adult testicular phenotype but that this phenotype does not
deteriorate with aging. Reduced adult testis size most commonly
reflects reduced GC number per testis, but this was not the case in
SMARKO males which were normally fertile and exhibited only
focal areas of deficient spermatogenesis. This is in contrast to
PTM-ARKO and SCARKO mice which are azoospermic, have a
more homogeneous testicular phenotype and are infertile [7,8].
The patchy loss of GCs in SMARKO testes could reflect focal
hypoxia, which has been shown to result in GC death triggered by
DNA damage [46]. The testis normally maintains a low oxygen
tension [47], therefore any significant decrease in testicular blood
flow would likely result in hypoxia and testicular damage. Overall
blood flow was normal in SMARKO testes and only focal areas of
atrophy were identified as discussed above. It is possible that
ablating AR from the smooth muscle cells of the arterioles only
disturbs testicular microcirculation at its most distal parts, resulting
in focal areas of azoospermia in these regions. More general
hypoxic effects may be limited by the observed ‘compensatory’
increase in blood vessel size and overall blood vessel volume.
Interestingly, there was no significant difference in the proportion
of blood vessels in SMARKO testes at d21 (data not shown)
suggesting that any increase in blood vessel size in these mice must
happen after puberty, the age at which vasomotion begins [20].
Therefore, altered vasomotion could be one of the triggers for
Figure 4. Evaluation of Leydig cell (LC) function in SMARKO testes. A. There was a significant increase in interstitial volume in SMARKO adult
testes. B. Immunostaining for 3bHSD (red) and AR (green) demonstrating that LCs (arrow) and SCs (arrowhead) express AR in both SMARKO and
control testes. C. Quantification of LC size and number highlighting no significant change in either in SMARKO testes, compared to controls. D.
Relative expression of steroidogenesis enzymes (StAR, cyp11a, 3bHSD, Cyp17 and 17bHSD) and Inls3 in d100 control and SMARKO testes. Values are
mean 6 SEM (n = 4–6 mice), ** p,0.01, compared to controls littermates. Scale bars = 50 mm.
doi:10.1371/journal.pone.0013632.g004
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increased blood vessel size in these mice; this requires further
investigation.
As GC number was not significantly reduced in SMARKO
testes, the reduction in testis size in these animals is most probably
due to the reduction in seminiferous tubule lumen volume. Lumen
volume reflects seminiferous tubule fluid (STF) production by SCs,
which is androgen-dependent [7,48,49]. However, serum and
intra-testicular testosterone concentrations were normal in adult
SMARKO males, SCs normally expressed AR, and the expression
of androgen-dependent SC genes such as Eppin or Rhox 5 [7,8]
were also unchanged. Therefore the deficits in STF production in
SMARKOs are not explained by changes in androgen action on
SCs; further investigations are required to identify the mechanisms
underlying the apparent reduction in STF volume in these mice.
Some insight could be gained from observations in other testicular
compartments in SMARKO mice. For example, the increased
relative expression of 3bHSD and cyp11a in SMARKO d100
testes compared to controls is indicative of a compensatory
increase in some of the steroidogenesis enzymes in order to
maintain normal serum testosterone concentrations. Furthermore,
serum LH concentrations were significantly elevated in SMARKO
adult males while serum and intra-testicular testosterone concen-
trations were unaltered; this is in line with the concept of
compensatory LC failure and is in agreement with the phenotype
reported by Zhang et al when using the same SM22-Cre to ablate
AR expression [35]. Interestingly, as seen with SCs, LCs from
SMARKO mice appeared normal for most aspects investigated
such as number, size and AR expression but had reduced mRNA
Figure 5. Hormone concentrations in SMARKO and control adult males. A. Serum follicle stimulating hormone (FSH) concentrations were
not significantly different in SMARKO males, compared to controls, at d50 or d100. B. Serum luteinising hormone (LH) concentrations were
significantly increased in SMARKO males at d100, but not at d50 compared to controls. C. Serum testosterone concentrations were not significantly
different in SMARKO males, compared to controls at d50 or d100. D. Intra-testicular testosterone concentrations were not significantly altered in
SMARKO males at d100. Values are mean 6 SEM (n = 8–27 mice), ** p,0.01, compared to control littermates.
doi:10.1371/journal.pone.0013632.g005
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expression of the LC differentiation marker Insl3. These findings
therefore suggest that signalling via arteriole smooth muscle AR
affects LC function and differentiation, but our results do not allow
us to distinguish whether ablation of AR from arteriole smooth
muscle cells directly affects the LCs by unknown signalling
mechanisms or whether this impaired LC function and differen-
tiation is the result of altered fluid transport to and from the testis,
or both. Transport of fluids into the testis is perhaps more likely to
be affected than transport out of the testis, as AR is deleted from
the testicular arterioles of SMARKO males, which are responsible
for delivery of blood to the testis, rather than removal which
occurs via venules. Conversely, if testosterone was getting trapped
in the testes due to impaired transport out of the testis, intra-
testicular testosterone would be increased and this was not seen in
SMARKO mice. The hypothesis of impaired fluid delivery into
the testis could also offer some explanation for the reduction in
STF production as delivery of FSH, which can affect STF
production in immature rats [49], may also be impaired in
SMARKO mice. However, relative expression of ABP, an FSH-
dependent SC gene [50], is not significantly altered in SMARKO
adults compared to controls suggesting that FSH delivery to and
action in the testis is normal. Furthermore, it has been shown that
LH can affect vascular permeability, and so fluid exchange, by
increasing VEGF production [12,18,19], but testicular VEGF
mRNA expression was not significantly changed in adult
SMARKOs, despite elevated LH concentrations. This suggests
that VEGF-mediated changes in vascular permeability cannot
explain the phenotype observed in SMARKO testes. Our results
therefore suggest that testicular arteriole smooth muscle AR plays
a role in regulating normal LC function, possibly by mediating
testicular fluid exchange and microvascular blood flow within the
testis but the mechanisms need further investigation.
Fluid transfer between blood vessels and IF is mediated by
vasomotion in the testes [20,21,22]. When blood is flowing quickly
through the microvasculature, plasma filters from the blood into
the interstitium and vice versa when blood flows slowly [22]. As
discussed above, there was no significant change in overall blood
flow in SMARKO testes, compared to controls, but vasomotion
was reduced in SMARKO testes. Previous publications have
shown that testosterone is required for vasomotion [17,26] but it is
not known how or via which cells this effect is mediated. Our
results demonstrate for the first time that arteriole smooth muscle
AR is necessary for normal testicular vasomotion. However, it
unclear if this impaired vasomotion in SMARKO testes is due to a
lack of arteriole smooth muscle AR itself or if it is a secondary
problem due the testicular abnormalities such as the compensatory
LC failure. Reduced vasomotion but normal blood flow in
SMARKO testes suggests that, as opposed to the cyclical fast and
slow microvascular blood flow normally observed in the testes,
blood is likely to be constantly flowing quickly through SMARKO
testes which would reduce resorption back into the bloodstream
and result in an increase in IF volume. IF volume was not
measured directly in the present studies due to technical
limitations, but it is likely to be increased in SMARKO adult
testes as, when quantified stereologically, interstitial volume was
increased without any changes in LC volume. This pattern of
continuous blood flow through SMARKO testes is similar to that
previously shown to occur in control rats treated with hCG which
impairs vasomotion [20,39,40,41]. Serum LH, which signals
through the same receptors as hCG, was increased in SMARKO
males which could also offer some explanation for the impaired
vasomotion observed in these mice.
Previous researchers have shown that hCG exposure abolishes
vasomotion and increases blood vessel permeability in control
rats thereby increasing IF volume [39,40,41] but, to the best of
our knowledge, it is not known if mice respond in the same way;
we therefore tested this in our mouse model. Little is known
about how hCG (or elevated LH) affects vasomotion but it is
unlikely to act simply by increasing testosterone as supra-
physiological concentrations of testosterone do not prevent
vasomotion in rats [22]. As expected, hCG induced a significant
increase in serum testosterone in both control and SMARKO
mice suggesting that hCG is being delivered to the testis, that the
LCs are able to respond by producing more testosterone and that
this testosterone is able to leave the testis and enter the
bloodstream. However, the increase in serum testosterone was
greater in the hCG treated controls than in the KOs, providing
further evidence that LCs are not able to respond to stimulation
in SMARKOs as well as in controls. This may be due to the LC
compensatory failure observed in SMARKO testes which could
mean that LCs are already working close to their maximal level
so increased stimulation by hCG would not induce as great a LC
response as that seen in controls. This link between arteriole
smooth muscle AR signalling and LC function requires further
investigation.
As expected, testis size increased in all hCG-treated controls,
presumably due to an increase in IF, and vasomotion was absent
in most control testes 16 hours after hCG exposure. It is not clear
why vasomotion was still present in 2 control mice treated with
hCG, however both amplitude and frequency of vasomotion was
Figure 6. Evaluation of Sertoli cell (SC) function in SMARKO
testes. A. WT-1 staining (black) was used to identify SC nuclei and
highlighted their basal location in SMARKO and control males. B. SC
mean nuclear volume in SMARKO and control d100 testes. Values are
means 6 S.E.M. (n = 4–6 mice). Scale bars = 50 mm.
doi:10.1371/journal.pone.0013632.g006
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significantly reduced in these mice, compared to untreated
control mice. It is possible that the dose of or timing of hCG is
not optimal to inhibit vasomotion in all mice or that mice may
respond differently to hCG than rats do; this warrants further
investigation. Interestingly, unlike control testes, SMARKO testes
did not increase in size 16 hours after hCG treatment but
vasomotion was completely abolished in all SMARKO males.
The lack of testicular size increase in SMARKO males could be a
direct result of ablating smooth muscle AR but is more likely to
reflect the already increased IF volume in untreated SMARKO
testes or the impaired blood flow and/or LC function in
SMARKO males.
Together these results demonstrate that androgen action via
smooth muscle cells of testicular arterioles is important in
regulating LC function, vasomotion and testicular fluid dynamics
but is not essential for normal testis development or fertility.
However, it is not clear whether arteriole smooth muscle AR
signalling directly affects LC function which then affects blood
vessel function, or vice versa, or both. Further investigations are
required to understand the underlying mechanisms.
Figure 7. Vasomotion in SMARKO testes. A. Representative laser Doppler recordings of testicular blood flow in one control and two KO testes (1
minute each). B. Average vasomotion frequency was significantly reduced in d100 KO testes compared to controls. C. Average vasomotion
amplitude was significantly reduced in d100 KO testes compared to controls. D. There was no significant change in average blood flow (Pfu) through
d100 SMARKO testes compared to controls. E. Average proportion of blood vessels in d100 control and KO testes. Values are mean 6 SEM (n = 3–14
mice), * p,0.05, compared to control littermates.
doi:10.1371/journal.pone.0013632.g007
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